329 related articles for article (PubMed ID: 30150136)
1. Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential.
Wein MN; Foretz M; Fisher DE; Xavier RJ; Kronenberg HM
Trends Endocrinol Metab; 2018 Oct; 29(10):723-735. PubMed ID: 30150136
[TBL] [Abstract][Full Text] [Related]
2. The Salt-Inducible Kinases: Emerging Metabolic Regulators.
Sakamoto K; Bultot L; Göransson O
Trends Endocrinol Metab; 2018 Dec; 29(12):827-840. PubMed ID: 30385008
[TBL] [Abstract][Full Text] [Related]
3. Nuts and bolts of the salt-inducible kinases (SIKs).
Darling NJ; Cohen P
Biochem J; 2021 Apr; 478(7):1377-1397. PubMed ID: 33861845
[TBL] [Abstract][Full Text] [Related]
4. Salt-inducible kinase 2 and -3 are downregulated in adipose tissue from obese or insulin-resistant individuals: implications for insulin signalling and glucose uptake in human adipocytes.
Säll J; Pettersson AM; Björk C; Henriksson E; Wasserstrom S; Linder W; Zhou Y; Hansson O; Andersson DP; Ekelund M; Degerman E; Stenkula KG; Laurencikiene J; Göransson O
Diabetologia; 2017 Feb; 60(2):314-323. PubMed ID: 27807598
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3 proteins mediate inhibitory effects of cAMP on salt-inducible kinases (SIKs).
Sonntag T; Vaughan JM; Montminy M
FEBS J; 2018 Feb; 285(3):467-480. PubMed ID: 29211348
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of HDAC5 by SIK1 in AICAR-treated C2C12 myoblasts.
Takemori H; Katoh Hashimoto Y; Nakae J; Olson EN; Okamoto M
Endocr J; 2009; 56(1):121-30. PubMed ID: 18946175
[TBL] [Abstract][Full Text] [Related]
7. The diverse oncogenic and tumor suppressor roles of salt-inducible kinase (SIK) in cancer.
Du WQ; Zheng JN; Pei DS
Expert Opin Ther Targets; 2016; 20(4):477-85. PubMed ID: 26549013
[TBL] [Abstract][Full Text] [Related]
8. AMPKα-like proteins as LKB1 downstream targets in cell physiology and cancer.
Molina E; Hong L; Chefetz I
J Mol Med (Berl); 2021 May; 99(5):651-662. PubMed ID: 33661342
[TBL] [Abstract][Full Text] [Related]
9. Salt Inducible Kinase Signaling Networks: Implications for Acute Kidney Injury and Therapeutic Potential.
Taub M
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31262033
[TBL] [Abstract][Full Text] [Related]
10. Salt-inducible kinase (SIK) isoforms: their involvement in steroidogenesis and adipogenesis.
Katoh Y; Takemori H; Horike N; Doi J; Muraoka M; Min L; Okamoto M
Mol Cell Endocrinol; 2004 Mar; 217(1-2):109-12. PubMed ID: 15134808
[TBL] [Abstract][Full Text] [Related]
11. cAMP-elevation mediated by β-adrenergic stimulation inhibits salt-inducible kinase (SIK) 3 activity in adipocytes.
Berggreen C; Henriksson E; Jones HA; Morrice N; Göransson O
Cell Signal; 2012 Sep; 24(9):1863-71. PubMed ID: 22588126
[TBL] [Abstract][Full Text] [Related]
12. Salt-inducible Kinases Are Critical Determinants of Female Fertility.
Armouti M; Winston N; Hatano O; Hobeika E; Hirshfeld-Cytron J; Liebermann J; Takemori H; Stocco C
Endocrinology; 2020 Jul; 161(7):. PubMed ID: 32343771
[TBL] [Abstract][Full Text] [Related]
13. The potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis.
Sun Z; Jiang Q; Li J; Guo J
Signal Transduct Target Ther; 2020 Aug; 5(1):150. PubMed ID: 32788639
[TBL] [Abstract][Full Text] [Related]
14. Shifting the selectivity of pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamily.
Rak M; Tesch R; Berger LM; Shevchenko E; Raab M; Tjaden A; Zhubi R; Balourdas DI; Joerger AC; Poso A; Krämer A; Elson L; Lučić A; Kronenberger T; Hanke T; Strebhardt K; Sanhaji M; Knapp S
Eur J Med Chem; 2023 Jun; 254():115347. PubMed ID: 37094449
[TBL] [Abstract][Full Text] [Related]
15. Salt-inducible kinases: new players in pulmonary arterial hypertension?
António T; Soares-da-Silva P; Pires NM; Gomes P
Trends Pharmacol Sci; 2022 Oct; 43(10):806-819. PubMed ID: 35851157
[TBL] [Abstract][Full Text] [Related]
16. Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312.
Temal-Laib T; Peixoto C; Desroy N; De Lemos E; Bonnaterre F; Bienvenu N; Picolet O; Sartori E; Bucher D; López-Ramos M; Roca Magadán C; Laenen W; Flower T; Mollat P; Bugaud O; Touitou R; Pereira Fernandes A; Lavazais S; Monjardet A; Borgonovi M; Gosmini R; Brys R; Amantini D; De Vos S; Andrews M
J Med Chem; 2024 Jan; 67(1):380-401. PubMed ID: 38147525
[TBL] [Abstract][Full Text] [Related]
17. Salt-Inducible Kinase 1 Terminates cAMP Signaling by an Evolutionarily Conserved Negative-Feedback Loop in β-Cells.
Kim MJ; Park SK; Lee JH; Jung CY; Sung DJ; Park JH; Yoon YS; Park J; Park KG; Song DK; Cho H; Kim ST; Koo SH
Diabetes; 2015 Sep; 64(9):3189-202. PubMed ID: 25918234
[TBL] [Abstract][Full Text] [Related]
18. High-Throughput Implementation of the NanoBRET Target Engagement Intracellular Kinase Assay to Reveal Differential Compound Engagement by SIK2/3 Isoforms.
Jin HY; Tudor Y; Choi K; Shao Z; Sparling BA; McGivern JG; Symons A
SLAS Discov; 2020 Feb; 25(2):215-222. PubMed ID: 31849250
[TBL] [Abstract][Full Text] [Related]
19. Salt-inducible kinases (SIK) inhibition reduces RANKL-induced osteoclastogenesis.
Lombardi MS; Gilliéron C; Berkelaar M; Gabay C
PLoS One; 2017; 12(10):e0185426. PubMed ID: 28973003
[TBL] [Abstract][Full Text] [Related]
20. SIK (Salt-inducible kinase): regulation of ACTH-mediated steroidogenic gene expression and nuclear/cytosol redistribution.
Lin X; Takemori H; Doi J; Katoh Y; Okamoto M
Endocr Res; 2000 Nov; 26(4):995-1002. PubMed ID: 11196481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
